Login/Sign Up
Bosuvi 400 mg Tablet is used to treat certain cancers such as Philadelphia chromosome-positive chronic myeloid leukaemia. It contains Bosutinib, which belongs to the class of kinase inhibitors. It works by inhibiting the action of abnormal proteins that cause the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduces the spread of cancer to other parts of the body.
₹6150*
MRP ₹7500
18% off
₹6375*
MRP ₹7500
15% CB
₹1125 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
About Bosuvi 400 mg Tablet
Bosuvi 400 mg Tablet is an anti-cancer medicine used in the treatment of Leukemia. Leukemia, also known as blood cancer, is a cancer of blood cells or blood-forming tissues. It causes excessive production of immature white blood cells by the bone marrow and reduces the body’s ability to fight infections. Bosuvi 400 mg Tablet is used in the treatment of chronic myelogenous leukemia (CML). This medicine is used in patients with chronic, accelerated, or blast phase Ph+ (Philadelphia chromosome-positive) chronic myelogenous leukemia who are resistant or intolerant to prior therapy.
Bosuvi 400 mg Tablet contains Bosutinib, which belongs to the class of kinase inhibitors. It works by inhibiting the action of abnormal proteins that cause the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body.
Bosuvi 400 mg Tablet may cause certain side effects, such as rash, fatigue, headache, back pain, decreased platelet count, back pain, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, and dizziness. These side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor. Bosuvi 400 mg Tablet should be taken as advised by your doctor. Do not take more than the recommended dose of medicine. Your doctor will decide the dose of Bosuvi 400 mg Tablet based on the severity of your condition.
Bosuvi 400 mg Tablet should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. Before taking this medicine, inform your doctor if you have liver/kidney disease, gastrointestinal toxicity, myelosuppression, fluid retention, and hepatic toxicity, as may cause serious side effects or worsen such conditions. This medicine is known to cause embryo-fetal toxicity. Hence, inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment with Bosuvi 400 mg Tablet . Breastfeeding should be discontinued in nursing mothers during the treatment. Bosuvi 400 mg Tablet is not recommended for use in children below 18 years of age as the safety and efficacy are not established.
Uses of Bosuvi 400 mg Tablet
Medicinal Benefits
Bosuvi 400 mg Tablet contains Bosutinib, which belongs to the class of kinase inhibitors. It works by inhibiting the action of abnormal proteins that cause the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body.
Side Effects of Bosuvi 400 mg Tablet
Directions for Use
Storage
Drug Warnings
Bosuvi 400 mg Tablet should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. Before taking, inform your doctor if you have liver/kidney disease, diabetes, cardiac problems, increased blood pressure, gastrointestinal toxicity, myelosuppression, fluid retention, and hepatic toxicity, as the use of Bosuvi 400 mg Tablet in these patients may cause serious side effects. This medicine is known to cause embryo-fetal toxicity. Hence, inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment. Breastfeeding should be discontinued in nursing mothers during the treatment. Bosuvi 400 mg Tablet is not recommended for use in children below 18 years of age as the safety and efficacy are not established. Avoid alcohol consumption and smoking, as it can lead to serious adverse effects.
Therapeutic Class
Drug-Drug Interactions
Drug-Food Interactions
Diet & Lifestyle Advise
Habit Forming
How Bosuvi 400 mg Tablet Works
What if I have taken an overdose of Bosuvi 400 mg Tablet
Alcohol
Unsafe
Avoid alcohol consumption while on treatment with Bosuvi 400 mg Tablet to prevent serious adverse effects.
Pregnancy
Unsafe
Bosuvi 400 mg Tablet is not recommended for use in pregnancy as it may harm your fetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before taking Bosuvi 400 mg Tablet . Your doctor may prescribe this medicine if the benefits outweigh the risks.
Breast Feeding
Caution
Limited data is available on the effect of Bosuvi 400 mg Tablet on breastfeeding. Bosuvi 400 mg Tablet should be avoided during breastfeeding. Hence, inform your doctor if you are breastfeeding. Your doctor may prescribe an alternative based on the symptoms and health condition.
Driving
Unsafe
Bosuvi 400 mg Tablet may cause dizziness and may make you feel drowsy. Hence, avoid driving or operating machines after taking Bosuvi 400 mg Tablet or until you become alert.
Liver
Caution
Bosuvi 400 mg Tablet is known to cause hepatotoxicity. Hence, inform your doctor if you have a pre-existing or a history of liver disease. A dose adjustment may be needed based on your condition.
Kidney
Caution
If you have a pre-existing or a history of kidney disease, inform your doctor before taking Bosuvi 400 mg Tablet . Your doctor may reduce the dose of this medicine or prescribe a suitable alternative based on your condition.
Children
Unsafe
Bosuvi 400 mg Tablet is not recommended for use in children below 18 years of age as the safety and efficacy are not established.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes